Amgen Said to Consider Actelion Ltd. Takeover Bid to Gain Rare Disease Drugs

Published: Nov 17, 2010

ZURICH (Reuters) - Shares in Actelion (ATLN.VX) soared on Wednesday on reports that the world's largest biotech firm Amgen (AMGN.O) is studying a takeover offer for the Swiss drugmaker, which says it is in "regular dialogue" with other industry players.

Back to news